Genprex, Inc. Made Headway

Tue, Jan 21, 2020 at 05:30 PM

Genprex, Inc. (GNPX:NASDAQ) soared at $1.15, a gain of 219.4%. The stock appeared on our News Catalysts scanner on Tue 21 Jan 20 at 09:18 AM in the 'BIOTECH' category.

About Genprex, Inc. (GNPX:NASDAQ)

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.

Top 10 Gainers:

Genprex, Inc. (GNPX:NASDAQ), 219.44%
NanoViricides, Inc. (NNVC:NYSEMKT), 152.98%
CSS Industries, Inc. (CSS:NYSE), 100%
Novavax, Inc. (NVAX:NASDAQ), 71.08%
BioPharmX Corporation (BPMX:NYSEMKT), 59.57%
AIM ImmunoTech Inc. (AIM:NYSEMKT), 47.95%
China Pharma Holdings, Inc. (CPHI:NYSEMKT), 39.88%
Alpha Pro Tech, Ltd. (APT:NYSEMKT), 38.57%
iBio, Inc. (IBIO:NYSEMKT), 36.23%
Vaxart, Inc. (VXRT:NASDAQ), 35.9%